companydata.dkcompanydata.dk

NORDIC LABORATORIES ApS: Financial statements 2022

CVR: 26672953

Source: annual report 2022, Danish Business Authority

01/07/2021 – 30/06/2022

NORDIC LABORATORIES ApS (CVR 26672953) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 7,326,122 and a net result of DKK -762,459 compared with DKK 2,243,120 the year before. That is a decrease of 18.5% compared with the year before. Equity in the 2022 report amounted to DKK 1,239,638. The solvency ratio was 23%. The company had 12 employees in the financial year.

Gross Profit
DKK 7,326,122
Profit/Loss
DKK -762,459
Equity
DKK 1,239,638
Total Assets
DKK 5,378,458
Employees
12

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-7.3 mio.-762 t.1.2 mio.12
2021-9 mio.2.2 mio.4.9 mio.11
2020-7.6 mio.1.7 mio.4.2 mio.10
2019-6.7 mio.1.6 mio.3 mio.8
2018-4.3 mio.540 t.1.6 mio.15

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on NORDIC LABORATORIES ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

About NORDIC LABORATORIES ApS

NORDIC LABORATORIES ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2002. The company is registered under the industry Aktiviteter inden for hospitalsvæsen. The company was previously named ApS KBIL 38 NR. 2431. The management consists of Christopher John Liebe Moore. The company is owned by NORDIC GROUP ApS. The company has 22 employees (2026). In 2025, the company reported a gross profit of DKK 11,578,808 and a net result of DKK 2,826,553 compared with DKK 4,319,759 the year before. Equity in the 2025 report amounted to DKK 4,080,445.

Source: annual report 2025, Danish Business Authority